XML 14 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statement of Stockholders' Equity - USD ($)
shares in Millions, $ in Millions
Total
Common Stock [Member]
Capital in Excess of Par Value [Member]
Retained Earnings [Member]
Accumulated Other Comprehensive Loss [Member]
Noncontrolling Interests [Member]
Beginning balance at Dec. 31, 2023 $ 10,815.3 $ 216.7 $ 7,297.8 $ 4,052.9 $ (792.1) $ 40.0
Beginning balance (in shares) at Dec. 31, 2023   216.7        
Net earnings 612.7     608.4   4.3
Net purchase of subsidiary shares from noncontrolling interests (0.3)         (0.3)
Dividends paid to noncontrolling interests (0.6)         (0.6)
Net change in pension asset/liability, net of taxes 0.3       0.3  
Foreign currency translation (155.8)       (155.8)  
Change in fair value of derivative instruments, net of taxes (1.4)       (1.4)  
Compensation expense related to stock option plan grants 15.1   15.1      
Common stock issued in: purchase transactions 88.3 $ 0.4 87.9      
Common stock issued in: purchase transactions (in shares)   0.4        
Stock option plans 39.9 $ 0.6 39.3      
Stock option plans (in shares)   0.6        
Employee stock purchase plan 12.2 $ 0.1 12.1      
Employee stock purchase plan (in shares)   0.1        
Shares issued to benefit plans 98.5 $ 0.4 98.1      
Shares issued to benefit plans (in shares)   0.4        
Deferred compensation and restricted stock (48.0) $ 0.3 (48.3)      
Deferred compensation and restricted (in shares)   0.3        
Cash dividends declared on common stock (132.0)     (132.0)    
Ending balance at Mar. 31, 2024 11,344.2 $ 218.5 7,502.0 4,529.3 (949.0) 43.4
Ending balance, (in shares) at Mar. 31, 2024   218.5        
Beginning balance at Dec. 31, 2024 $ 20,179.6 $ 250.0 16,068.9 4,985.7 (1,151.1) 26.1
Beginning balance (in shares) at Dec. 31, 2024 250.0 250.0        
Net earnings $ 708.9     704.4   4.5
Net purchase of subsidiary shares from noncontrolling interests 3.0         3.0
Net change in pension asset/liability, net of taxes (0.1)       (0.1)  
Foreign currency translation 217.3       217.3  
Change in fair value of derivative instruments, net of taxes (0.1)       (0.1)  
Compensation expense related to stock option plan grants 17.8   17.8      
Common stock issued in: purchase transactions 16.6 $ 0.1 16.5      
Common stock issued in: purchase transactions (in shares)   0.1        
Stock option plans $ 68.6 $ 0.7 67.9      
Stock option plans (in shares) 0.7 0.7        
Employee stock purchase plan $ 14.1 $ 0.1 14.0      
Employee stock purchase plan (in shares)   0.1        
Stock issuance from public offering 1,252.1 $ 4.6 1,247.5      
Stock issuance from public offering, shares   4.6        
Shares issued to benefit plans 119.6 $ 0.3 119.3      
Shares issued to benefit plans (in shares)   0.3        
Deferred compensation and restricted stock (76.5) $ 0.3 (76.8)      
Deferred compensation and restricted (in shares)   0.3        
Cash dividends declared on common stock (167.2)     (167.2)    
Ending balance at Mar. 31, 2025 $ 22,353.7 $ 256.1 $ 17,475.1 $ 5,522.9 $ (934.0) $ 33.6
Ending balance, (in shares) at Mar. 31, 2025 256.1 256.1